Latest Monoclonal antibodies Stories
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit.
Scientists at the inter-university Messerli Research Institute of the Vetmeduni Vienna, the Medical University of Vienna, and the University of Vienna have developed, for the first time, antibodies to treat cancer in dogs.
High demand for chromatography reagents in the pharmaceutical industry and innovation in chromatography reagents market will propel the global size exclusion chromatography reagents market.
MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of
COLLEGE PARK, Md., July 1, 2014 /PRNewswire-USNewswire/ --The University of Maryland (UMD) Fischell Department of Bioengineering
SAN DIEGO, July 1, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer THOUSAND OAKS, Calif., July 1, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced
Scientists with Texas A&M AgriLife Research have found a "Trojan horse" way to deliver proteins into live human cells without damaging them.
An interdisciplinary research team from the University of Texas Medical Branch at Galveston, the Uniformed Services University of the Health Sciences and three groups within the National Institutes of Health reports a new breakthrough in countering the deadly Nipah virus.
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- To swell, as grain or wood with water.
More Images (1 images) »